4//SEC Filing
SANDS ARTHUR T 4
Accession 0001549595-24-000017
CIK 0001549595other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 7:22 AM ET
Size
5.4 KB
Accession
0001549595-24-000017
Insider Transaction Report
Form 4
SANDS ARTHUR T
DirectorPresident, CEO
Transactions
- Award
Employee Stock Option (right to buy)
2024-02-13+800,000→ 800,000 totalExercise: $8.72Exp: 2034-02-12→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/36 of the total shares monthly beginning March 13, 2024, until the option is fully vested on February 13, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Nurix Therapeutics, Inc.
CIK 0001549595
Entity typeother
Related Parties
1- filerCIK 0001134106
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 7:22 AM ET
- Size
- 5.4 KB